These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 28551354)

  • 21. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
    Fang J; Seki T; Maeda H
    Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant treatment in Alzheimer's disease: current state.
    Gilgun-Sherki Y; Melamed E; Offen D
    J Mol Neurosci; 2003; 21(1):1-11. PubMed ID: 14500988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidant properties and neuroprotective effects of isocampneoside II on hydrogen peroxide-induced oxidative injury in PC12 cells.
    Si CL; Shen T; Jiang YY; Wu L; Yu GJ; Ren XD; Xu GH; Hu WC
    Food Chem Toxicol; 2013 Sep; 59():145-52. PubMed ID: 23770344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidant therapy in Alzheimer's disease: theory and practice.
    Aliev G; Obrenovich ME; Reddy VP; Shenk JC; Moreira PI; Nunomura A; Zhu X; Smith MA; Perry G
    Mini Rev Med Chem; 2008 Nov; 8(13):1395-406. PubMed ID: 18991755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
    Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
    Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of common free radicals and antioxidants on development of Alzheimer's Disease.
    Wojtunik-Kulesza KA; Oniszczuk A; Oniszczuk T; Waksmundzka-Hajnos M
    Biomed Pharmacother; 2016 Mar; 78():39-49. PubMed ID: 26898423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism.
    Gunasingh MJ; Philip JE; Ashok BS; Kirubagaran R; Jebaraj WC; Davis GD; Vignesh S; Dhandayuthapani S; Jayakumar R
    Life Sci; 2008 Jul; 83(3-4):96-102. PubMed ID: 18590917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles.
    Nazıroğlu M; Muhamad S; Pecze L
    Expert Rev Clin Pharmacol; 2017 Jul; 10(7):773-782. PubMed ID: 28463572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
    Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease.
    Choi DY; Lee YJ; Hong JT; Lee HJ
    Brain Res Bull; 2012 Feb; 87(2-3):144-53. PubMed ID: 22155297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The two faces of reactive oxygen species].
    Zabłocka A; Janusz M
    Postepy Hig Med Dosw (Online); 2008 Mar; 62():118-24. PubMed ID: 18388851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of peroxynitrite in the vasoactive and cytotoxic effects of Alzheimer's beta-amyloid1-40 peptide.
    Paris D; Parker TA; Town T; Suo Z; Fang C; Humphrey J; Crawford F; Mullan M
    Exp Neurol; 1998 Jul; 152(1):116-22. PubMed ID: 9682018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidant pathways in Alzheimer's disease: possibilities of intervention.
    Viña J; Lloret A; Giraldo E; Badia MC; Alonso MD
    Curr Pharm Des; 2011 Dec; 17(35):3861-4. PubMed ID: 21933145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological importance of reactive oxygen species in relation to difficulties of treating pathologies involving oxidative stress by exogenous antioxidants.
    Juránek I; Nikitovic D; Kouretas D; Hayes AW; Tsatsakis AM
    Food Chem Toxicol; 2013 Nov; 61():240-7. PubMed ID: 24025685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemistry and pharmacological properties of some natural and synthetic antioxidants for heavy metal toxicity.
    Flora SJ; Shrivastava R; Mittal M
    Curr Med Chem; 2013; 20(36):4540-74. PubMed ID: 24206124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox cycling of endogenous copper by ferulic acid leads to cellular DNA breakage and consequent cell death: A putative cancer chemotherapy mechanism.
    Sarwar T; Zafaryab M; Husain MA; Ishqi HM; Rehman SU; Rizvi MM; Tabish M
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):251-61. PubMed ID: 26415834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease.
    Begni B; Brighina L; Sirtori E; Fumagalli L; Andreoni S; Beretta S; Oster T; Malaplate-Armand C; Isella V; Appollonio I; Ferrarese C
    Free Radic Biol Med; 2004 Sep; 37(6):892-901. PubMed ID: 15304259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cu(II)-coumestrol interaction leads to ROS-mediated DNA damage and cell death: a putative mechanism for anticancer activity.
    Zafar A; Singh S; Naseem I
    J Nutr Biochem; 2016 Jul; 33():15-27. PubMed ID: 27260464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential role of nanoyttria in alleviating oxidative stress biomarkers: Implications for Alzheimer's disease therapy.
    Tang KS
    Life Sci; 2020 Oct; 259():118287. PubMed ID: 32814066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.